<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Detailed information on MDP32156
Description |
TCEA2 protein |
Sequence | MMGKEEEIARIARRLDKMVTKKSAEGAMDLLRELKAMPITLHLLQSTRVGMSVNALRKQSSDEEVIALAKSLIKSWKKLLDASDAKARERGRGMPLPTSSRDASEAPDPSRKRPELPRAPSTPRITTFPPVPVTCDAVRNKCREMLTAALQTDHDHVAIGADCERLSAQIEEYILWVGAVGLGFWWSQEAAWPGALWWLLDATAQLSRGHLPGWSPAWVVRLSHLRRAPGPAEGLILSACGA |
Length | 242 |
Position | Unknown |
Organism | Homo sapiens (Human) |
Kingdom | Metazoa |
Lineage | Eukaryota> Metazoa> Chordata> Craniata> Vertebrata> Euteleostomi> Mammalia>
Eutheria> Euarchontoglires> Primates> Haplorrhini> Catarrhini> Hominidae>
Homo.
|
Aromaticity | 0.05 |
Grand average of hydropathy | -0.266 |
Instability index | 62.92 |
Isoelectric point | 9.30 |
Molecular weight | 26655.57 |
Publications | PubMed=11780052
PubMed=11181995
PubMed=15489334
PubMed=22814378
|
Function
Annotated function |
|
GO - Cellular Component | centrosome GO:0005813 IDA:HPA
nucleoplasm GO:0005654 IDA:HPA
|
GO - Biological Function | translation elongation factor activity GO:0003746 IEA:UniProtKB-KW
|
GO - Biological Process | transcription, DNA-templated GO:0006351 IEA:InterPro
|
Interaction
Repeat regions
Repeats |
>MDP32156
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
2| 65.05| 19| 19| 81| 99| 1
---------------------------------------------------------------------------
81- 99 (34.63/18.26) DASDAKARERGR.GMPLPTS
102- 121 (30.42/15.29) DASEAPDPSRKRpELPRAPS
---------------------------------------------------------------------------
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
2| 43.48| 14| 19| 137| 151| 3
---------------------------------------------------------------------------
137- 151 (19.58/18.24) AVRNKCrEMLTAALQ
158- 171 (23.90/16.38) AIGADC.ERLSAQIE
---------------------------------------------------------------------------
|
Associated diseases